A detailed history of Barometer Capital Management Inc. transactions in Bio N Tech Se stock. As of the latest transaction made, Barometer Capital Management Inc. holds 2,260 shares of BNTX stock, worth $244,599. This represents 0.08% of its overall portfolio holdings.

Number of Shares
2,260
Previous 2,260 -0.0%
Holding current value
$244,599
Previous $182 Million 47.8%
% of portfolio
0.08%
Previous 0.07%

Shares

1 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q2 2024

Aug 09, 2024

BUY
$80.36 - $102.87 $181,613 - $232,486
2,260 New
2,260 $182 Million

Others Institutions Holding BNTX

About BioNTech SE


  • Ticker BNTX
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 242,684,992
  • Market Cap $26.3B
  • Description
  • BioNTech SE, a biotechnology company, develops and commercializes immunotherapies for cancer and other infectious diseases. The company is developing FixVac product candidates, including BNT111, which is in Phase II clinical trial for advance melanoma; BNT112 that is in Phase I/IIa clinical trial for prostate cancer; BNT113, which is in Phase II...
More about BNTX
Track This Portfolio

Track Barometer Capital Management Inc. Portfolio

Follow Barometer Capital Management Inc. and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Barometer Capital Management Inc., based on Form 13F filings with the SEC.

News

Stay updated on Barometer Capital Management Inc. with notifications on news.